Exactech Innovations Presented at 2016 Orthopaedic Research Society Annual Meeting
March 03 2016 - 9:00AM
Business Wire
Studies Include Reverse Shoulder Surgery, Hip
and Knee Arthroplasty, and Impact of ExactechGPS® Computer Assisted
Technology in Orthopaedic Surgery
Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone
and joint restoration products for extremities, knee, hip, spine
and biologic materials, will present more than 25 scientific
posters and presentations regarding its latest product and
instrumentation advancements as well as the use of ExactechGPS®
computer assisted technology in orthopaedic surgery during the 2016
Orthopaedic Research Society (ORS) annual meeting, March 5 – 8 in
Orlando, Fla.
Research included cadaveric computer-controlled studies,
clinical outcome studies and bench test studies with topics ranging
from reverse shoulder surgery and hip and knee arthroplasty to the
impact of computer assisted surgery and alternatives for cartilage
repair.
“The wide-ranging scope and quality of these studies are a great
example of the way Exactech employees embody our value of
innovation and our commitment to improving patient outcomes with
proven advancements,” said Exactech Co-founder and Executive Vice
President of Research and Development Gary Miller, PhD. “It’s
rewarding to see both basic scientific and clinical information
that result from collaboration among our scientists, engineers and
surgeon partners. I’m proud to see these teams recognized for the
contributions they are making to our field.”
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160303005176/en/
Exactech Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance & Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: EXAC@hawkassociates.comorMedia contactPriscilla
Bennett, 352-377-1140Vice President, Corporate & Marketing
Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024